Condition

Chemoradiotherapy clinical trials and research

• 19Clinical trials
• 2NIH research projects
• 3Countries

Newest Chemoradiotherapy clinical trials

All recruiting trials (19)

• Audit of cervical cancer chemoradiation guideline compliance across National Cancer Grid centers

  This project will check how closely hospitals across India follow recommended chemoradiation treatments for patients with cervical cancer.

  Recruiting at 2 sites Tata Memorial Hospital · Mumbai, Maharashtra and 1 other locations · NCT07290972

• Thiopegfilgrastim to prevent bone marrow suppression during chemoradiotherapy for esophageal or lung cancer

  This will try mecapegfilgrastim (a long-acting G-CSF) to prevent low neutrophil counts in adults with esophageal or lung cancer receiving concurrent chemoradiotherapy.

  Recruiting Phase 2 Affiliated Hospital of Nantong University · Nantong, Jiangsu · NCT07205536

• Short-course pelvic radiotherapy followed by CAPOX (capecitabine + oxaliplatin) and bevacizumab, with or without PD‑1 immunotherapy, for locally advanced rectal cancer.

  This trial tests whether adding a PD‑1 immunotherapy to short-course radiotherapy followed by CAPOX and bevacizumab helps adults with locally advanced rectal cancer get a higher complete response rate and fewer distant metastases.

  Recruiting Phase 2 Ruijin Hospital · Shanghai · NCT07198165

• Toripalimab plus capecitabine after chemoradiotherapy for esophageal squamous cell carcinoma

  This trial will test whether giving toripalimab together with low‑dose capecitabine after definitive chemoradiotherapy helps people with locally advanced esophageal squamous cell carcinoma live longer and have fewer recurrences.

  Recruiting Phase 3 Sun Yat-sen University · Guangzhou, Guangdong · NCT07177794

• Weekly electronic symptom tracking during definitive chemoradiotherapy for lung cancer

  This project will test whether weekly electronic questionnaires can map symptom severity and clusters in adults with unresectable stage III non-small cell or limited-stage small cell lung cancer receiving definitive concurrent chemoradiotherapy.

  Recruiting Tongji Hospital · Wuhan, Hubei · NCT07131670

• QL1706 with chemotherapy induction followed by immunotherapy consolidation in limited-stage SCLC after chemoradiotherapy

  This study tests if QL1706 given with chemotherapy induction can improve outcomes for adults with limited-stage small cell lung cancer after chemoradiation, with follow-up immunotherapy consolidation and biomarker analysis.

  Recruiting Phase 2 Shanghai Chest Hospital · Shanghai · NCT07091305

• Surufatinib with chemo-immunotherapy and chemoradiotherapy for unresectable locally advanced esophageal squamous cell carcinoma

  This trial will test whether adding surufatinib to two cycles of chemo-immunotherapy followed by concurrent chemoradiotherapy helps people with unresectable, locally advanced esophageal squamous cell carcinoma.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT07086469

• Comparing total neoadjuvant therapy with surgery for rectal cancer treatment

  This study is testing if rectal cancer patients who respond well to a new treatment can skip surgery and just be monitored to see how they do compared to those who have surgery right away.

  Recruiting Phase 2/3 National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos · Vilnius · NCT06758830

• Combining chemotherapy and immunotherapy for limited-stage small cell lung cancer

  This study is testing a new treatment that combines chemotherapy and immunotherapy to see if it can help people with limited-stage small cell lung cancer live longer and feel better.

  Recruiting Phase 2 Sun Yat-sen University · Guangzhou, Guangdong · NCT06719700

• Nimotuzumab with Chemoradiotherapy for Esophageal Cancer

  This study is testing if a combination of a new antibody treatment, chemotherapy, and radiation can help older or malnourished patients with advanced esophageal cancer feel better and improve their chances of recovery.

  Recruiting Phase 2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing · NCT06429839

• Combining immunotherapy and chemoradiotherapy for esophageal cancer treatment

  This study is testing if combining a new immunotherapy drug with traditional chemoradiotherapy can help people with advanced esophageal cancer have better treatment results.

  Recruiting Phase 2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Anyang, Henan and 2 other locations · NCT06421376

• Using sintilimab after chemoradiotherapy for elderly patients with esophageal cancer

  This study is testing if adding a new treatment called sintilimab after chemotherapy and radiation can help older patients with esophageal cancer live longer and healthier.

  Recruiting Phase 2 Zhejiang Cancer Hospital · Hangzhou, Zhejiang · NCT06413342

• Nimotuzumab with Chemoradiotherapy for Unresectable Esophageal Cancer

  This study is testing if adding a new drug called nimotuzumab to chemotherapy and radiation can help patients with advanced esophageal cancer who haven't improved with earlier treatments.

  Recruiting Phase 2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Beijing · NCT06410651

• Combining Toripalimab with Chemoradiotherapy for Cervical Cancer

  This study is testing if adding an immunotherapy drug called toripalimab to standard treatment can help women with newly diagnosed locally advanced cervical cancer do better than with just the standard treatment alone.

  Recruiting Ruijin Hospital · Shanghai, Shanghai Municipality · NCT06256224

• Impact of Nutrition on Cancer Treatment Outcomes in Shaanxi

  This study is testing how a cancer patient's nutrition affects their treatment results and overall well-being during chemotherapy and radiation in Shaanxi Province.

  Recruiting Xi'an Jiaotong University · Xi'an, Shaanxi · NCT06219083

• Combining immunonutrition with chemoradiotherapy for inoperable esophageal cancer

  This study is testing whether a special nutritional formula can help people with inoperable esophageal cancer live longer and feel better when combined with chemoradiotherapy.

  Recruiting Anhui Provincial Hospital · Hefei · NCT05833594

• Treatment for advanced cervical cancer using chemoradiotherapy and additional chemotherapy

  This study is testing if adding extra chemotherapy to standard chemoradiotherapy can help people with advanced cervical cancer live longer and stay healthier.

  Recruiting Phase 3 Fourth Affiliated Hospital of Guangxi Medical University · Liuzhou, Guangxi · NCT05735145

• Treatment options for elderly patients with esophageal squamous cell carcinoma

  This study is testing whether combining chemotherapy with radiation helps older patients over 75 with advanced esophageal cancer live longer and feel better compared to just radiation alone.

  Recruiting at 3 sites Fudan University · Nanjing, Jiangsu and 2 other locations · NCT04519905

• Chemoradiotherapy for patients with unresectable esophageal cancer

  This study is testing a new combination of chemotherapy and radiation to see if it helps people with advanced esophageal cancer while also focusing on their nutrition to improve their treatment experience.

  Recruiting at 5 sites Phase 1/2 Cancer Institute and Hospital, Chinese Academy of Medical Sciences · Anyang, Henan and 4 other locations · NCT04278287

NIH-funded research (2)

Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.

• Using radiation to help chemotherapy reach head, neck, and thyroid tumors

  This project looks at whether targeted radiation can change head and neck and anaplastic thyroid tumors so long‑lasting chemotherapy reaches them more safely and works better.

  NIH research Massachusetts General Hospital · Boston, United States · NIH-11294368

• Improving drug delivery for safer cancer treatment using radiation

  This study is looking at how using radiation therapy can help make chemotherapy work better for people with advanced head and neck cancers, aiming to improve treatment results while reducing side effects.

  NIH research Massachusetts General Hospital · Boston, United States · NIH-11127053

Related topics

Quick answers

How many Chemoradiotherapy clinical trials are recruiting right now?

19, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 3 countries. The most sites are in China (17 trials), India (1 trial), Lithuania (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 2: 9, Phase 3: 2, Phase 2/3: 1, Phase 1/2: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →